Professional Documents
Culture Documents
Stedmans-Lab Reference Range Values
Stedmans-Lab Reference Range Values
qxd
8/13/05
1:45 PM
Page APP 96
APP 96
8/13/05
1:45 PM
Page APP 97
APP 97
Acetaminophen, serum or
plasma (Hep or
EDTA)
Therapeutic
Toxic
Acetone
Serum
Qualitative
Quantitative
Urine
Qualitative
Acid hemolysis test (Ham)
Adrenocorticotropin (ACTH),
plasma
8 AM
Midnight (supine)
*Alanine aminotransferase (ALT,
SGPT), serum
Male
Female
Albumin
Serum
Adult
>60 y
Urine
Qualitative
Quantitative
CSF
*Aldolase, serum
Aldosterone
Serum
Supine
Standing
Urine
Amikacin, serum or plasma
(EDTA)
Therapeutic
Peak
Trough
Less severe infection
Life-threatening infection
Toxic
Peak
Trough
]-Aminolevulinic acid, urine
Amitriptyline, serum or plasma
(Hep or EDTA);
trough ($12 h after
dose)
Therapeutic
Toxic
Ammonia
Plasma (Hep)
*Amylase
Serum
Urine
Amylase:creatinine clearance
ratio
Conventional Units
SI Units
1030 mcg/mL
>200 mcg/mL
66199 mcmol/L
>1324 mcmol/L
Negative
0.32.0 mg/dL
Negative
0.050.34 mmol/L
Negative
<5% lysis
Negative
<0.05 lysed fraction
<120 pg/mL
<10 pg/mL
<26 pmol/L
<2.2 pmol/L
3.55.2 g/dL
3.24.6 g/dL
Avg. of 0.3 g/dL higher in patients
in upright position
3552 g/L
3246 g/L
Avg. of 3 g/L higher in patients
in upright position
Negative
5080 mg/24 h
1030 mg/dL
1.07.5 U/L (30C)
Negative
5080 mg/24 h
100300 mg/L
0.020.13 mckat/L (30C)
316 ng/dL
730 ng/dL
319 mcg/24 h
0.080.44 nmol/L
0.190.83 nmol/L
851 nmol/24 h
2535 mcg/mL
4360 mcmol/L
14 mcg/mL
48 mcg/mL
1.76.8 mcmol/L
6.813.7 mcmol/L
>3540 mcg/mL
>1015 mcg/mL
1.37.0 mg/24 h
>6068 mcmol/L
>1726 mcmol/L
1053 mcmol/24 h
80250 ng/mL
>500 ng/mL
289903 nmol/L
>1805 nmol/L
933 mcmol/L
933 mcmol/L
27131 U/L
117 U/h
14%
0.462.23 mckat/L
0.017-0.29 mckat/h
0.010.04
APP 98
8/13/05
1:45 PM
Page APP 98
Conventional
Conventional
Units
Units
Androstenedione, serum
Male
Female
Anion gap
(Na [Cl + HCO3]])
([Na + K] [Cl + HCO3])
a1-Antitrypsin, serum
Apolipoprotein A-1
Male
Female
Apolipoprotein B
Male
Female
Arsenic
Whole blood (Hep)
Chronic poisoning
Acute poisoning
Urine, 24 h
Ascorbic acid, plasma (Ox, Hep, EDTA)
*Aspartate aminotransferase
(AST, SGOT), serum
Base excess, blood (Hep)
Bicarbonate, serum (venous)
*Bilirubin
Bilirubin, direct
Birthdeath
Bilirubin, total
Birth1 day
12 days
25 days
5 daysdeath
Total bilirubin, neonatal
Birth1 day
12 days
25 days
5 days1 month
1 monthdeath
Bone marrow, differential cell count
Adult
Undifferentiated cells
Myeloblast
Promyelocyte
Myelocytes
Neutrophilic
Eosinophilic
Basophilic
Metamyeolocytes and bands
Neutrophilic
Eosinophilic
Basophilic
Segmented neutrophils
Pronormoblast
Basophilic normoblast
Polychromatophilic normoblast
Orthochromatic normoblast
Lymphocytes
Plasma cells
Monocytes
CA-125, serum
CA 15-3, serum
SI Units
SI Units
75205 ng/dL
85275 ng/dL
2.67.2 nmol/L
3.09.6 nmol/L
716 mEq/L
1020 mEq/L
78200 mg/dL
716 mmol/L
1020 mmol/L
0.782.00 g/L
94178 mg/dL
101199 mg/dL
0.941.78 g/L
1.011.99 g/L
63133 mg/dL
60126 mg/dL
0.631.33 g/L
0.601.26 g/L
0.22.3 mcg/dL
1050 mcg/dL
60930 mcg/dL
550 mcg/d
0.41.5 mg/dL
1059 U/L (37C)
0.030.31 mcmol/L
1.336.65 mcmol/L
7.98124 mcmol/L
0.070.67 mcmol/d
2385 mcmol/L
0.171.00 -2 to +3 kat/L (37C)
22 to +3 mEq/L
2229 mEq/L
22 to +3 mmol/L
2229 mmol/L
0.00.4 mg/dL
1.06.0 mg/dL
6.07.5 mg/dL
4.013.5 mg/dL
0.21.2 mg/dL
1.06.0 mg/dL
6.07.5 mg/dL
4.013.5 mg/dL
0.01.8 mg/dL
0.01.8 mg/dL
01%
02%
0-4%
00.01
00.02
00.04
520%
03%
01%
0.050.20
00.03
00.01
535%
05%
01%
515%
01.5%
05%
530%
510%
1020%
02%
05%
<35 U/mL
<30 U/mL
0.050.35
00.05
00.01
0.050.15
00.015
00.05
0.050.30
0.050.10
0.100.20
00.02
00.05
<35 kU/L
<30 kU/L
8/13/05
1:45 PM
Page APP 99
APP 99
CA 19-9, serum
Cadmium, whole blood (Hep)
Toxic
Cadmium, urine, 24 h
Calcitonin, serum or plasma
Male
Female
Calcium, serum
Calcium, ionized, serum
Calcium, urine
Low calcium diet
Usual diet; trough
Carbamazepine, serum or plasma
(Hep or EDTA), trough
Therapeutic
Toxic
Carbon dioxide, total, serum/
plasma (Hep)
Carbon dioxide (PCO2),
blood, arterial
Carbon monoxide as
carboxyhemoglobin
(HbCO), whole blood
(EDTA)
Nonsmokers
Smokers
12 packs/d
>2 packs/d
Toxic
Lethal
Carotene, serum
Catecholamines, plasma
(EDTA)
Dopamine
Epinephrine
Norepinephrine
Catecholamines, urine
Dopamine
Epinephrine
Norepinephrine
CEA, serum
Nonsmokers
*Cell counts, adult
Erythrocytes
Male
Female
Leukocytes
Total
Differential
Myelocytes
Neutrophils
Band
Segmented
Lymphocytes
Monocytes
Granulocytes
Eosinophils
Basophils
Platelets
(continued )
Conventional Units
SI Units
<37 U/mL
0.10.5 mcg/dL
10300 mcg/dL
<15 mcg/d
<37 kU/L
8.944.5 nmol/L
0.8926.70 mcmol/L
<0.13 mcmol/d
#100 pg/mL
#30 pg/mL
8.610.0 mg/dL
(Slightly higher in children)
4.645.28 mg/dL
#100 ng/L
#30 ng/L
2.152.50 mmol/L
(Slightly higher in children)
1.161.32 mmol/L
50150 mg/24 h
100300 mg/24 h
1.253.75 mmol/24 h
2.507.50 mmol/24 h
412 mcg/mL
>15 mcg/mL
2228 mmol/L
1751 mcmol/L
>63 mcmol/L
2228 mmol/L
Male
3548 mmHg
Female 3245 mmHg
4.666.38 kPa
4.265.99 kPa
0.51.5% total Hb
45% total Hb
89% total Hb
>20% total Hb
>50% total Hb
1085 mcg/dL
< 30 pg/mL
<140 pg/mL
<1700 pg/mL
<196 pmol/L
<764 pmol/L
<10,047 pmol/L
65400 mcg/24 h
020 mcg/24 h
1580 mcg/24 h
4252610 nmol/24 h
0109 nmol/24 h
89473 nmol/24 h
<5.0 ng/mL
<5.0 mcg/L
4.76.1 3 106/mcL
4.25.4 3 106/mcL
4.76.1 3 1012/L
4.25.4 3 1012/L
4.810.8 3 103/mcL
Percentage
Absolute
0
0/mcL
4.810.8 3 106/L
Absolute (SI)
0/L
35
5462
20.551.1
1.79.3
42.275.2
150400 3 106/L
30005800 3 106/L
1.23.4 3 109/L
0.110.59 3 109/L
1.46.5 3 109/L
00.7 3 109/L
00.2 3 109/L
130400 3 109/L
150400/mcL
30005800/mcL
1.23.4 x 103/mcL
0.110.59 x 103/mcL
1.46.5 x 103/mcL
00.7 x 103/mcL
00.2 x 103/mcL
3
130400 x 10 /mcL
APP 100
8/13/05
1:45 PM
Conventional Units
SI Units
0.0050.015 of RBCs
2484 3 109/L
0-10 lymphocytes/mm3
0 RBC/mm3
0.20.6 g/L
3177 mcmol/L
>77 mcmol/L
98107 mmol/L
535 mmol/L
60200 mmol/L
210 mmol/24h
1540 mmol/24h
110250 mmol/24 h
118132 mmol/L (20 mmol/L
higher than serum)
<5.2 mmol/L
5.26.2 mmol/L
$6.2 mmol/L
4.911.9 kU/L
0.790.84
0.580.64
<5.0 IU/L
Negative
Positive
48190 nmol/L
>254 nmol/L
0.81.2 of normal
06 min
16 min
2.39.5 min
0.51.0/2 h
515 min (glass tubes)
1960 min (siliconized tubes)
No hemolysis
75160 kU/L
8/13/05
1:45 PM
APP 101
Conventional
Units
Conventional
Units
SI SI
Units
Units
previous page)
1020%
Deficiency: >50%
14.922.1 mg/dL
2.510.0 mg/dL
5.010.0 mg/dL
1.63.6 mg/dL
90180 mg/dL
1040 mg/dL
5.511.3 mg/dL
17.923.9 mg/dL
2.77.4 mg/dL
4.910.6 mg/dL
3.39.5 mg/dL
149221 mg/L
25100 mg/L
50100 mg/L
1636 mg/L
0.91.8 g/L
0.1-0.4 g/L
55113 mg/L
179239 mg/L
2774 mg/L
49106 mg/L
3395 mg/L
Negative
Negative
Negative
Negative
70140 mcg/dL
80155 mcg/dL
335 mcg/24 h
1122 mcmol/L
1324 mcmol/L
0.050.55 mcmol/24 h
2731 pg
3337 g/dL
0.420.48 fmol
330370 g/L
8094 fL
8199 fL
Cortisol, serum
Plasma (Hep, EDTA, Ox)
8 AM
523 mcg/dL
4 PM
316 mcg/dL
10 PM
<50% of 8 AM value
<50 mcg/24 h
Free, urine
*Creatine kinase (CK), serum
15105 U/L (30C)
Male
Female
1080 U/L (30C)
Note: Strenuous exercise or intramuscular injections may elevate transient CK levels.
*Creatine kinase MB isoenzyme,
07 ng/mL
serum
*Creatinine
Serum or plasma, adult
Male
0.71.3 mg/dL
Female
0.61.1 mg/dL
Urine
Male
1426 mg/kg body
weight/24 h
Female
1120 mg/kg body
weight/24 h
*Creatinine clearance, serum
or plasma and urine
Male
94140 mL/min/1.73 m2
Female
72110 mL/min/1.73 m2
Cryoglobulins, serum
0
**Test values dependent on laboratory methods used.
Test values dependent on patients race.
138635 nmol/L
83441 nmol/L
<0.5 of 8 AM value
<138 mmol/24 h
0.261.79 mckat/L (30C)
0.171.36 mckat/L (30C)
07 mcg/L
62115 mcmol/L
5397 mcmol/L
124230 mcmol/kg body
weight/24 h
97177 mcmol/kg body
weight/24 h
0.911.35 mL/s/m2
0.691.06 mL/s/m2
0
APP 102
8/13/05
1:45 PM
Cyanide
Serum
Nonsmokers
Smokers
Nitroprusside therapy
Toxic
Whole blood (Ox)
Nonsmokers
Smokers
Nitroprusside therapy
Toxic
Cyclic AMP
Plasma (EDTA)
Male
Female
Urine, 24 h
Conventional Units
SI Units
0.004 mg/L
0.006 mg/L
0.010.06 mg/L
>0.1 mg/L
0.15 mcmol/L
0.23 mcmol/L
0.382.30 mcmol/L
>3.84 mcmol/L
0.016 mg/L
0.041 mg/L
0.050.5 mg/L
>1 mg/L
0.61 mcmol/L
1.57 mcmol/L
1.9219.20 mcmol/L
>38.40 mcmol/L
4.68.6 ng/mL
4.37.6 ng/mL
0.33.6 mg/d
or 0.292.1 mg/g creatinine
Negative
1426 nmol/L
1323 nmol/L
1.010.9 mcmol/d or
100723 mcmol/mol creatinine
Negative
0.260.62 nmol/L
<5 mg/L
83166 nmol/L
6.243.3 nmol/L
4.534.0 nmol/L
1.612.2 mcmol/L
0.810.2 mcmol/L
0.87.1 mcmol/L
2811125 nmol/L
>1500 nmol/L
0.353.51 mcmol/L
>17.55 mcmol/L
2646 nmol/L
>59 nmol/L
1.01.9 nmol/L
1.92.6 nmol/L
>3.2 nmol/L
>3.8 nmol/L
8/13/05
1:45 PM
APP 103
Conventional Units
SI Units
2.83.2 mcg/mL
3.37.5 mcg/mL
>7 mcg/mL
8.39.4 mcmol/L
9.722 mcmol/L
>20.7 mcmol/L
150250 ng/mL
>500 ng/mL
537895 nmol/L
>1790 nmol/L
1050 pg/mL
Varies with menstrual cycle
37-184 pmol/L
>100 mg/dL
>400 mg/dL
>21.7 mmol/L
>86.8 mmol/L
40100 mcg/mL
>150 mcg/mL
No lysis in 2 h
<15 ng/mL
283708 mcmol/L
>1062 mcmol/L
No lysis in 2 h
<15 mcg/L
<1 g/d
<2 g/d
<7 g/d
<4 g/d
190240 mg/dL
825 mg/dL
715 mmol/L
0.280.89 mmol/L
20150 ng/mL
20250 mcg/L
10120 ng/mL
10120 mcg/L
have been reported to be generally associated with depleted iron stores.
<10 mcg/mL
<10 mg/L
200400 mg/dL
24 g/L
0.010.2 mcg/mL
0.23.2 mcg/mL
<8 mcg/mL
320 ng/mL
140628 ng/mL RBC
0.510.5 mcmol/L
10.5168 mcmol/L
<421 mcmol/L
745 nmol/L
3171422 nmol/L RBC
1.415.4 mIU/mL
1.415.4 IU/L
110 mIU/mL
110 IU/L
APP 104
8/13/05
1:45 PM
Conventional
Conventional
Units
Units
SI SI
Units
Units
617 IU/L
19 IU/L
19100 IU/L
4.213
<100 ng/L
10.416.7 mcmol
16.720.9 mcmol/L
<2.1 mcmol/L
<4.2 mcmol/L
<4.28.4 mcmol/L
>2125 mcmol/L
>4.28.4 mcmol/L
3.55.3 mmol/L
4.15.9 mmol/L
<6.7 mmol/L
<2.8 mmol/24 h
Negative
2.23.9 mmol/L
0.78 0.13 mU/mol Hb
0.35 0.06 nU/RBC
4.11 0.71 kU/L RBC
<5 mcg/L
<10 mcg/L
0.32.0 g/L
8/13/05
1:45 PM
APP 105
Conventional Units
SI Units
200239 mg/dL
>240 mg/dL
<150 mg/dL
150199 mg/dL
>200 mg/dL
4252%
3747%
5365%
3043%
0.420.52
0.370.47
0.530.65
0.300.43
14.018.0 g/dL
12.016.0 g/dL
17.023.0 g/dL
11.216.5 g/dL
$1 y old: <2% of total Hb
<3 mg/dL
Negative
2.172.79 mmol/L
1.862.48 mmol/L
2.643.57 mmol/L
1.742.56 mmol/L
$1 y old: <0.02% of total Hb
<0.47 mcmol/L
Negative
>95%
1.53.7%
<2%
Negative
>0.95 Hb fraction
0.0150.037 Hb fraction
<0.02 Hb fraction
Negative
0.212.81 mg/dL
20270 mcmol/L
310 mg/24 h
28 mg/24 h
Negative
27 mg/24 h
Negative
10.436.6 mcmol/24 h
150250 ng/mL
>500 ng/mL
536893 nmol/L
>1785 nmol/L
7001600 mg/dL
70400 mg/dL
40230 mg/dL
08 mg/dL
3423 IU/mL
0.56.1 mg/dL
225 mcU/mL
716 g/L
0.74.0 g/L
0.42.3 g/L
080 mg/L
3423 kIU/L
0.56.1 g/L
13174 pmol/L
65175 mcg/dL
50170 mcg/dL
250425 mcg/dL
11.631.3 mcmol/L
9.030.4 mcmol/L
44.871.6 mcmol/L
APP 106
8/13/05
1:45 PM
Conventional
Conventional
Units
Units
SI SI
Units
Units
2050%
1550%
0.20.5
0.150.5
1025 mg/24 h
614 mg/24 h
(decreases with age)
3887 mcmol/24 h
2152 mcmol/24 h
(decreases with age)
4.519.8 mg/dL
4.514.4 mg/dL
0.52.2 mmol/L
0.51.6 mmol/L
8.115.3 mg/dL
<11.3 mg/dL
4961982 mg/d
1022 mg/dL
0.91.7 mmol/L
<1.3 mmol/L
5.522 mmol/d
1.12.4 mmol/L
290775 U/L
5452000 U/L
180430 U/L
110295 U/L
100190 U/L
110210 U/L
4.913.2 mckat/L
9.334 mckat/L
3.17.3 mckat/L
1.95 mckat/L
1.73.2 mckat/L
1.93.6 mckat/L
1426% of total
2939% of total
2026% of total
816% of total
616% of total
10% of serum value
<130 mg/dL
130159 mg/dL
160 mg/dL
<.2 mmol/L
3.374.12 mmol/L
4.13 mmol/L
<25 mcg/dL
<80 mcg/d
2.05.0 indicates probable fetal
lung maturity; .3.5 in
diabetic patients
<0.48 mcmol/L
<0.39 mcmol/d
2.0-5.0 indicates probable fetal
lung maturity;
>3.5 in diabetic patients
1.56.0 mcg/mL
6.426 mcmol/L
68 mcg/mL
>8 mcg/mL
2634.2 mcmol/L
>34.2 mcmol/L
0.61.2 mEq/L
>2 mEq/L
0.61.2 mmol/L
>2 mmol/L
50240 ng/mL
156746 nmol/L
L-Lactate
Plasma (NaF)
Venous
Arterial
Whole blood (Hep), at bed rest
Venous
Arterial
Urine, 24 h
CSF
*Lactate dehydrogenase
Total (LP), 37C, serum
Newborn
Neonate
Infant
Child
Adult
>60 y
*Isoenzymes, serum by agarose
gel electrophoresis
Fraction 1
Fraction 2
Fraction 3
Fraction 4
Fraction 5
*Lactate dehydrogenase, CSF
LDL-cholesterol (LDL-C), serum
or plasma (EDTA)
Adult desirable
borderline
high risk
Lead,
Whole blood (Hep)
Urine, 24 h
Lecithin-sphingomyelin (L:S)
ratio, amniotic fluid
Lidocaine, serum or plasma
(Hep or EDTA); 45 min
after bolus dose
Therapeutic
Toxic
CNS, cardiovascular depression
Seizures, obtundation,
decreased cardiac
output
*Lipase, serum
Lithium, serum or plasma (Hep
or EDTA); 12 h after
last dose
Therapeutic
Toxic
Lorazepam, serum or plasma
(Hep or EDTA),
therapeutic
8/13/05
1:45 PM
APP 107
Conventional Units
SI Units
1.247.8 mIU/mL
1.247.8 IU/L
1.6815.0
21.956.6
0.6116.3
14.252.5
1.6815.0
21.956.6
0.6116.3
14.252.3
mIU/mL
mIU/mL
mIU/mL
mIU/mL
IU/L
IU/L
IU/L
IU/L
1.32.1 mEq/L
1.62.6 mg/dL
6.010.0 mEq/24 h
0.651.07 mmol/L
1626 mg/L
3.05.0 mmol/24 h
0.659 mcg/L
<20 mcg/d
>150 mcg/d
0.11.6 mg/24 h
0.060.24 g/dL or
0.78 0.37% of total Hb (SD)
<0.29 mcmol/L
<0.1 mcmol/d
>0.75 mcmol/d
0.58.1 mcmol/24 h
9.337.2 mcmol/L or
mass fraction of total Hb:
0.008 0.0037 (SD)
Variable
Variable
$0.02 mcmol/L
$5 mcmol/L
$0.5 mcmol/L
$0.05 mcmol/L
<2.5 ng/mL
<85 ng/mL
$0.02 mcmol/L
$5 mcmol/L
$0.5 mcmol/L
$0.05 mcmol/L
<2.5 mcg/L
<85 mcg/L
50150 ng/mL
>500 ng/mL
217 U/L
190570 nmol/L
>1900 nmol/L
0.0340.29 mckat/L
530 mcg/mL
>40 mcg/mL
Negative (<2 mL blood/150 g
stool/d)
Negative
18108 mcmol/L
>144 mcmol/L
Negative (<13.3 mL blood/kg
stool/d)
Negative
APP 108
8/13/05
1:45 PM
Oxygen, blood
Capacity
Content
Arterial
Venous
Saturation
Arterial and capillary
Venous
Tension
pO2 arterial and capillary
Venous
P50, blood
Partial thromboplastin time
activated (APTT)
Pentobarbital, serum or plasma
(Hep or EDTA); trough
Therapeutic
Hypnotic
Therapeutic coma
Toxic
pH
Blood, arterial
Urine
Phenacetin, plasma (EDTA)
Therapeutic
Toxic
Phenobarbital, serum or plasma
(Hep or EDTA); trough
Therapeutic
Toxic
Slowness, ataxia, nystagmus
Coma with reflexes
Coma without reflexes
Phenolsulfonphthalein (PSP) excretion,
urine
Phenylalanine, serum
Phenytoin, serum or plasma
(Hep or EDTA); trough
Therapeutic
Toxic
*Phosphatase, acid, prostatic, serum
radioimmunoassay
*Phosphatase, alkaline,
total, serum
Phosphate, inorganic, serum
Adults
Children
Phosphatidylglycerol, amniotic fluid
Fetal lung immaturity
Fetal lung maturity
Phospholipids, serum
Phosphorus, urine
Porphobilinogen, urine
Qualitative
Quantitative
Conventional Units
SI Units
1523 vol%
1016 vol%
6.6910.3 mmol/L
4.467.14 mmol/L
9598% of capacity
6085% of capacity
0.950.98 of capacity
0.600.85 of capacity
83108 mmHg
3545 mmHg
2529 mmHg (adjusted to pH 7.4)
<35 sec
11.114.4 kPa
4.66.0 kPa
3.333.86 kPa
<35 sec
15 mcg/mL
2050 mcg/mL
>10 mcg/mL
422 mcmol/L
88221 mcmol/L
>44 mcmol/L
7.357.45
4.68.0 (depends on diet)
7.357.45
Same
130 mcg/mL
50250 mcg/mL
6167 mcmol/L
2791395 mcmol/L
1540 mcg/mL
65172 mcmol/L
3580 mcg/mL
65117 mcg/mL
>100 mcg/mL
2851% in 15 min
1324% in 30 min
917% in 60 min
310% in 2 h
(After injection of 1 mL PSP
intravenously)
0.81.8 mg/dL
151345 mcmol/L
280504 mcmol/L
>430 mcmol/L
0.280.51 in 15 min
0.130.24 in 30 min
0.090.17 in 60 min
0.030.10 in 2 h
(After injection of 1 mL PSP
intravenously)
48109 mcmol/L
1020 mcg/mL
>20 mcg/mL
4079 mcmol/L
>79 mcmol/L
<3.0 ng/mL
38126 U/L (37C)
<3.0 mcg/L
0.652.14 mckat/L
2.74.5 mg/dL
4.55.5 mg/dL
0.871.45 mmol/L
1.451.78 mmol/L
absent
present
125275 mg/dL
0.41.3 g/24 h
absent
present
1.252.75 g/L
12.942 mmol/24 h
Negative
<2.0 mg/24 h
Negative
<9 mcmol/24 h
8/13/05
1:45 PM
APP 109
Porphyrins, urine
Coproporphyrin
Uroporphyrin
Potassium, plasma (Hep)
Males
Females
Potassium
Serum
Premature
Cord
48 h
Newborn, cord
Newborn
Infant
Child
Adult
Urine, 24 h
CSF
Conventional Units
SI Units
34230 mcg/24 h
2752 mcg/24 h
52351 nmol/24 h
3263 nmol/24 h
3.54.5 mEq/L
3.44.4 mEq/L
3.54.5 mmol/L
3.44.4 mmol/L
5.010.2 mEq/L
3.06.0 mEq/L
5.612.0 mEq/L
3.75.9 mEq/L
4.15.3 mEq/L
3.44.7 mEq/L
3.55.1 mEq/L
25125 mEq/d, varies with diet
70% of plasma level or 2.53.2
mEq/L; rises with
plasma hyperosmolality
1040 mg/dL
5.010.2 mmol/L
3.06.0 mmol/L
5.612.0 mmol/L
3.75.9 mmol/L
4.15.3 mmol/L
3.44.7 mmol/L
3.55.1 mmol/L
25125 mmol/d; varies with diet
0.70 of plasma level or 2.53.2
mmol/L; rises with
plasma hyperosmolality
100400 mg/L
512 mcg/mL
>15 mcg/mL
2355 mcmol/L
>69 mcmol/L
410 mcg/mL
>1012 mcg/mL
1742 mcmol/L
.4251 mcmol/L
1397 ng/dL
0.43.1 nmol/L
1570 ng/dL
2002500 ng/dL
Varies with gestational week
0.52.2 nmol/L
6.479.5 nmol/L
2.515.0 ng/mL
2.519.0 ng/mL
2.515.0 mcg/L
2.519.0 mcg/L
0.10.4 mcg/mL
>0.5 mcg/mL
0.31.2 mcmol/L
>1.5 mcmol/L
50100 ng/mL
193386 nmol/L
<4.0 ng/mL
<4.0 mcg/L
6.48.3 g/dL
3.95.1 g/dL
6483 g/L
3951 g/L
0.20.4
0.40.8
0.51.0
0.61.3
24 g/L
48 g/L
510 g/L
613 g/L
g/dL
g/dL
g/dL
g/dL
Negative
5080 mg/24 h (at rest)
832 mg/dL
Negative
Same
80320 mg/dL
APP 110
8/13/05
1:45 PM
Conventional Units
Prothrombin consumption
Prothrombin time-international normalized
INR: birth6 mo
INR: 6 moadult
Protoporphyrin, total, WB
Pyruvate, blood
Quinidine, serum or plasma
(Hep or EDTA); trough
Therapeutic
Toxic
Salicylates, serum or plasma
(Hep or EDTA); trough
Therapeutic
Toxic
#Sedimentation rate, erythrocyte
Westergren
Male: 050 y
Male: >50 y
Female: 050 y
Female: >50 y
Wintrobe
Males
Females
Critical value
Sodium
Serum or plasma (Hep)
Premature
Cord
48 h
Newborn, cord
Newborn
Infant
Child
Adult
Urine, 24 h
Sweat
Normal
Cystic fibrosis
Specific gravity, urine
*Testosterone, serum
Male
Female
Pregnancy
Postmenopausal
SI Units
>20 sec
ratio (see NOTES below)
1.01.6
0.91.2
<60 mcg/dL
0.30.9 mg/dL
<600 mcg/L
34103 mcmol/L
25 mcg/mL
>6 mcg/mL
615 mcmol/L
>18 mcmol/L
150300 mcg/mL
>500 mcg/mL
1.092.17 mmol/L
.3.62 mmol/L
015
020
020
030
>20 sec
mm/h
mm/h
mm/h
mm/h
<10 mm/h
<20 mm/h
>75 mm/h
116140 mEq/L
128148 mEq/L
126166 mEq/L
133146 mEq/L
139146 mEq/L
138145 mEq/L
136145 mEq/L
40220 mEq/d (diet
dependent)
116140 mmol/L
128148 mmol/L
126166 mmol/L
133146 mmol/L
139146 mmol/L
138145 mmol/L
136145 mmol/L
40220 mmol/d (diet
dependent)
1040 mEq/L
70190 mEq/L
1.0021.030
1040 mmol/L
70190 mmol/L
1.0021.030
2801100 ng/dL
1570 ng/dL
34 3 normal
835 ng/dL
0.5238.17 nmol/L
0.522.43 nmol/L
34 x normal
0.281.22 nmol/L
NOTE:
NOTE:
NOTE:
INR=[(Patient PT)/(Normal PT)] *ISI where ISI is the international sensitivity index, a value provided by the reagent manufacturer.
target therapeutic range (international normalized ratio) of 2.03.0. http://pediatrics.aappublications.org/cgi/content/full/112/5/e386
The American College of Chest Physicians has recommended a therapeutic INR range for adults of 2.03.0, except in patients with mechanical cardiac valves who should have an INR of 2.53.5. 1target INR range of 2.63.8 for children with heart disease and a slightly lower range of
2.13.3 for treating children with established venous thrombosis. Clinicians at Torontos Hospital for Sick Children used an INR range of 2.03.0
initially but later found that a lower target of 1.31.8 was as effective and resulted in no bleeding complications.
http://www.healthsystem.virginia.edu/internet/pediatrics/pharma-news/jan95.pdf
NOTE: The recommended therapeutic target for the treatment and prevention of venous thromboembolisms and pulmonary embolisms in an INR of
2.5 with a range between 2.03.0, and children with mechanical prosthetic heart valves have a recommended therapeutic INR range of 3.0 INR
range between 2.53.5. Evaluate at that time. http://www.warfarinfo.com/pediatrics.htm
*Test values dependent on laboratory methods used.
# http://www.labcorp.com/datasets/labcorp/html/chapter/mono/he005000.htm;
http://www.utmb.edu/lsg/LabSurvivalGuide/hem/Sedimentation_Rate.htm
8/13/05
1:45 PM
APP 111
Conventional Units
SI Units
820 mcg/mL
613 mcg/mL
>20 mcg/mL
44111 mcmol/L
3372 mcmol/L
>110 mcmol/L
14 mcg/mL
312 mcg/mL
629 mcg/mL
1769 mcmol/L
52206 mcmol/L
103499 mcmol/L
14 mg/d
717 mg/d
1769 mcmol/d
120292 mcmol/d
1.05.0 mcg/mL
30100 mcg/mL
7130 mcg/mL
>10 mcg/mL
0.44.2 mcU/mL
4.120.7 mcmol/L
124413 mcmol/L
29536 mcmol/L
>41 mcmol/L
0.44.2 mU/L
58 mcg/mL
810 mcg/mL
1117 mcmol/L
1721 mcmol/L
<1 mcg/mL
<2 mcg/mL
<24 mcg/mL
<2 mcmol/L
<4 mcmol/L
<49 mcmol/L
>1012 mcg/mL
>24 mcg/mL
>2126 mcmol/L
>49 mcmol/L
130275 mg/dL
212360 mg/dL
190375 mg/dL
1.302.75 g/L
2.123.60 g/L
1.93.75 g/L
<250 mg/dL
250500 mg/dL
>500 mg/dL
100-200 ng/dL
undetectable
undetectable
620 mg/dL
12:1 to 20:1
<2.83 mmol/L
2.835.67 mmol/L
>5.65 mmol/L
1.54-3.8 nmol/L
undetectable
undetectable
2.17.1 mmol urea/L
4880 urea:creatinine mole ratio
4.58.0 mg/dL
2.56.2 mg/dL
0.270.47 mmol/L
0.150.37 mmol/L
APP 112
8/13/05
1:45 PM
Conventional Units
SI Units
2.05.5 mg/dL
250750 mg/24 h
(with normal diet)
0.10.8 Ehrlich unit/2 h
0.54.0 Eu/d
0.120.32 mmol/L
1.484.43 mmol/24 h
(with normal diet)
0.1-0.8 Eu/2h
0.54.0 Eu/d
50100 mcg/mL
>100 mcg/mL
347693 mcmol/L
>693 mcmol/L
2040 mcg/mL
510 mcg/mL
>80100 mcg/mL
1.46.5 mg/24 h
1428 mcmol/L
37 mcmol/L
>5569 mcmol/L
733 mcmol/d
1.001.24 cP
3080 mcg/dL
110800 pg/mL
1.001.24 cP
1.052.8 mcmol/L
81590 pmol/L
518 mcg/mL
3050 mcg/mL
70120 mcg/dL
1242 mcmol/L
69.6116 mcmol/L
10.718.4 mcmol/L